Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MK7634 described in world patent

Aug. 9, 1996

Antiviral pyrimidine derivatives described by Nippon Shoji

Aug. 9, 1996

Novel oxazolidinone antibacterial agents reported by Bayer

Aug. 9, 1996

Antibacterial peptides from Sanwa Kagaku

Aug. 9, 1996

Beta-Lactamase inhibitors for treatment of penicillin-resistant infections

Aug. 9, 1996

Licensing agreement signed for rifaximin

Aug. 9, 1996

SmithKline Beecham acquires worldwide rights to Cantab's TA-GW vaccine

July 26, 1996

Chlorhexidine gluconate effective in reducing incidence of nosocomial respiratory tract infections

July 26, 1996

Sequus and Zeneca restructure Amphotec marketing agreement

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...